These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 17095155)

  • 1. Immunoreactivity of 43 kDa growth-associated protein is decreased in post mortem hippocampus of bipolar disorder and schizophrenia.
    Tian SY; Wang JF; Bezchlibnyk YB; Young LT
    Neurosci Lett; 2007 Jan; 411(2):123-7. PubMed ID: 17095155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth-associated protein 43 (GAP-43) and synaptophysin alterations in the dentate gyrus of patients with schizophrenia.
    Chambers JS; Thomas D; Saland L; Neve RL; Perrone-Bizzozero NI
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Feb; 29(2):283-90. PubMed ID: 15694236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of hippocampal brain-derived neurotrophic factor and its receptors in Stanley consortium brains.
    Dunham JS; Deakin JF; Miyajima F; Payton A; Toro CT
    J Psychiatr Res; 2009 Sep; 43(14):1175-84. PubMed ID: 19376528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulation of the initiating step of the kynurenine pathway in postmortem anterior cingulate cortex from individuals with schizophrenia and bipolar disorder.
    Miller CL; Llenos IC; Dulay JR; Weis S
    Brain Res; 2006 Feb; 1073-1074():25-37. PubMed ID: 16448631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neural stem cell proliferation is decreased in schizophrenia, but not in depression.
    Reif A; Fritzen S; Finger M; Strobel A; Lauer M; Schmitt A; Lesch KP
    Mol Psychiatry; 2006 May; 11(5):514-22. PubMed ID: 16415915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Region and diagnosis-specific changes in synaptic proteins in schizophrenia and bipolar I disorder.
    Gray LJ; Dean B; Kronsbein HC; Robinson PJ; Scarr E
    Psychiatry Res; 2010 Jul; 178(2):374-80. PubMed ID: 20488553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in the cellular distribution of D1 receptor mRNA in the hippocampus of bipolars and schizophrenics.
    Pantazopoulos H; Stone D; Walsh J; Benes FM
    Synapse; 2004 Dec; 54(3):147-55. PubMed ID: 15452863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical and immunoblot analysis of Dopamine and cyclic AMP-regulated phosphoprotein, relative molecular mass 32,000 (DARPP-32) in the prefrontal cortex of subjects with schizophrenia and bipolar disorder.
    Ishikawa M; Mizukami K; Iwakiri M; Asada T
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Aug; 31(6):1177-81. PubMed ID: 17521792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alteration in estrogen receptor alpha mRNA levels in frontal cortex and hippocampus of patients with major mental illness.
    Perlman WR; Tomaskovic-Crook E; Montague DM; Webster MJ; Rubinow DR; Kleinman JE; Weickert CS
    Biol Psychiatry; 2005 Nov; 58(10):812-24. PubMed ID: 16112656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of synapsin in the hippocampus of patients with bipolar disorder and schizophrenia.
    Vawter MP; Thatcher L; Usen N; Hyde TM; Kleinman JE; Freed WJ
    Mol Psychiatry; 2002; 7(6):571-8. PubMed ID: 12140780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vesicular glutamate transporter mRNA expression in the medial temporal lobe in major depressive disorder, bipolar disorder, and schizophrenia.
    Uezato A; Meador-Woodruff JH; McCullumsmith RE
    Bipolar Disord; 2009 Nov; 11(7):711-25. PubMed ID: 19839996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in neuroanatomical sites of apoD elevation discriminate between schizophrenia and bipolar disorder.
    Thomas EA; Dean B; Scarr E; Copolov D; Sutcliffe JG
    Mol Psychiatry; 2003 Feb; 8(2):167-75. PubMed ID: 12610649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hippocampal FGF-2 and FGFR1 mRNA expression in major depression, schizophrenia and bipolar disorder.
    Gaughran F; Payne J; Sedgwick PM; Cotter D; Berry M
    Brain Res Bull; 2006 Jul; 70(3):221-7. PubMed ID: 16861106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical and immunoblot analysis of gamma-aminobutyric acid B receptor in the prefrontal cortex of subjects with schizophrenia and bipolar disorder.
    Ishikawa M; Mizukami K; Iwakiri M; Asada T
    Neurosci Lett; 2005 Aug; 383(3):272-7. PubMed ID: 15955420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VASE-containing N-CAM isoforms are increased in the hippocampus in bipolar disorder but not schizophrenia.
    Vawter MP; Hemperly JJ; Hyde TM; Bachus SE; VanderPutten DM; Howard AL; Cannon-Spoor HE; McCoy MT; Webster MJ; Kleinman JE; Freed WJ
    Exp Neurol; 1998 Nov; 154(1):1-11. PubMed ID: 9875262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular abnormalities of the hippocampus in severe psychiatric illness: postmortem findings from the Stanley Neuropathology Consortium.
    Knable MB; Barci BM; Webster MJ; Meador-Woodruff J; Torrey EF;
    Mol Psychiatry; 2004 Jun; 9(6):609-20, 544. PubMed ID: 14708030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SNAP-25 reduction in the hippocampus of patients with schizophrenia.
    Thompson PM; Egbufoama S; Vawter MP
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 May; 27(3):411-7. PubMed ID: 12691775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of hippocampal volumes in schizophrenia, schizoaffective and bipolar disorder.
    Radonić E; Rados M; Kalember P; Bajs-Janović M; Folnegović-Smalc V; Henigsberg N
    Coll Antropol; 2011 Jan; 35 Suppl 1():249-52. PubMed ID: 21648342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deficient hippocampal neuron expression of proteasome, ubiquitin, and mitochondrial genes in multiple schizophrenia cohorts.
    Altar CA; Jurata LW; Charles V; Lemire A; Liu P; Bukhman Y; Young TA; Bullard J; Yokoe H; Webster MJ; Knable MB; Brockman JA
    Biol Psychiatry; 2005 Jul; 58(2):85-96. PubMed ID: 16038679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of POU-domain transcription factor, Oct-6, in schizophrenia, bipolar disorder and major depression.
    Ubhi K; Price J
    BMC Psychiatry; 2005 Oct; 5():38. PubMed ID: 16246257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.